Skip to main navigation
Horizon Therapeutics plc
Horizon Therapeutics menu
  • Our Company
    • About Us
    • Leadership Team
    • Corporate Social Responsibility
    • Partnering
    • Grant Programs
      • Medical Education
      • External Research
    • Worldwide Locations
    • Contact Us
  • Our Science
    • Research and Development
    • Pipeline
  • Our Medicines
    • Our Portfolio
    • Medicine Support
  • Our Patients
    • Our Commitment
    • Advocacy
      • Overview
      • Resources
    • Disease Information
    • Patient Stories
    • Patient Support
    • Expanded Access
  • Careers
    • Why Horizon
    • Who We Are
    • Benefits
    • Job Opportunities
  • Investors
    • At a Glance
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Whistleblower Hotline
      • Leadership
      • Committee Composition
      • Contact Board
    • Financials & Filings
      • Financial Information
      • SEC Filings
      • GAAP to Non-GAAP Reconciliations
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Annual Reports / Proxy Statements
    • Investors FAQs
    • IR Contact Us
    • IR Email Alerts
  • United States
    • Canada
  • Investors
  • Media Center
  • Follow Us
    • United States
    • Canada

Financial Information

Financial Information

Show all

Latest 10-Q

Filing date Form View
09/02/11 10-Q
0001193125-11-240251.pdf
0001193125-11-240251.rtf
0001193125-11-240251.xls
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Annual Reports

More information is coming soon.

Latest 10-Ks

Filing date Form View
03/23/12 10-K
0001193125-12-129945.pdf
0001193125-12-129945.rtf
0001193125-12-129945.xls
View HTMLEX-101.INS - XBRL INSTANCE DOCUMENT
04/25/12 ARS View HTML
03/18/13 10-K
0001193125-13-111071.pdf
0001193125-13-111071.rtf
0001193125-13-111071.xls
View HTMLEX-101.INS - XBRL INSTANCE DOCUMENT
04/29/13 ARS View HTML

Proxy Statements

Filing date Form View
04/30/12 DEF 14A
0001193125-12-194390.pdf
0001193125-12-194390.rtf
0001193125-12-194390.xls
View HTML
04/29/13 DEF 14A
0001193125-13-179602.pdf
0001193125-13-179602.rtf
0001193125-13-179602.xls
View HTML

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Whistleblower Hotline
    • Leadership Team
    • Committee Composition
    • Contact the Board
  • Financial & Filings
    • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Annual Reports / Proxy Statements
  • Investor FAQs
  • Contact Us
  • Email Alerts
Investor Contacts Tina Ventura
Senior Vice President,
Investor Relations
Investor-relations@horizontherapeutics.com

Ruth Venning
Executive Director,
Investor Relations
Investor-relations@horizontherapeutics.com
U.S. Media Contact Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief
Communications Officer
media@horizontherapeutics.com
+1 888 506-2562
Ireland Media Contact Ray Gordon
Gordon MRM
ray@gordonmrm.ie
+353 (87) 2417373
Shareholder Tools

Shareholder Tools

  • Email Alerts Subscription
  • RSS News Feeds
  • Snapshot
  • Print
  • Our Company
  • Our Science
  • Our Medicines
  • Our Patients
  • Careers
  • Investors
  • Follow Us
© 2021 Horizon Therapeutics plc
  • Global Privacy Policy
  • Legal Notice
  • Cookie Policy
  • Contact Us

The information regarding our medicines and the patients they treat on this site is intended only for residents of the U.S.

You are leaving horizontherapeutics.com

You are leaving horizontherapeutics.com. You will be redirected to a website operated by an independent third party. This link is provided solely for your convenience.

Continue